Reply to O. Sütcüoğlu et al, F. Negri et al, and B.C. Yüksel

Affiliations

¹ Yuan Tang, MD, State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China; Hai-Tao Zhou, MD, State Key Laboratory of Molecular Oncology and Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS and PUMC, Beijing, China; Ye-Xiong Li, MD, State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China; and Jing Jin, MD, State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China, Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, CAMS and PUMC, Shenzhen, China.

Comment

Yuan Tang et al. J Clin Oncol. 2022.

. 2022 Dec 1;40(34):4029-4031.

doi: 10.1200/JCO.22.01225. Epub 2022 Aug 5.

¹ Yuan Tang, MD, State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China; Hai-Tao Zhou, MD, State Key Laboratory of Molecular Oncology and Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS and PUMC, Beijing, China; Ye-Xiong Li, MD, State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China; and Jing Jin, MD, State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China, Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, CAMS and PUMC, Shenzhen, China.

No abstract available

Comment on

Unconsolidated Results of Consolidation Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer.
Negri F, Aschele C. Negri F, et al. J Clin Oncol. 2022 Dec 1;40(34):4028. doi: 10.1200/JCO.22.00923. Epub 2022 Aug 5. J Clin Oncol. 2022. PMID: 35930759 No abstract available.
Could the STELLAR Study Change the Rectal Cancer Treatment Algorithm?
Sütcüoğlu O, Özet A, Yazıcı O, Özdemir N. Sütcüoğlu O, et al. J Clin Oncol. 2022 Dec 1;40(34):4027. doi: 10.1200/JCO.22.00752. Epub 2022 Aug 5. J Clin Oncol. 2022. PMID: 35930767 No abstract available.